Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
‘Wu-Tang Forever: The Final Chamber’ tour — How to get tickets, presale times, concert dates and more- First stop, the Moon. Next stop, Mars? Why Nasa's mission matters
- At least 18 Palestinians killed in latest clashes in Gaza
- Figure out How to Get the Most Familiar Drive for Seniors in SUVs
- Sally Rooney books may be withdrawn from UK sale over Palestine Action ban, court told
- The Most Famous Virtual Entertainment Powerhouses of the Year
- Russia accidentally destroys its only way of sending astronauts to space
- Attorney-General to High Court: Gov’t violating draft ruling, risking rule of law
- I’m a dad to an autistic child. Here’s how you can make the holidays easier for all of us.
